Amniotic membrane extract eye drops for ocular surface diseases: use and clinical outcome in real-world practice

Purpose To study the indications and clinical outcomes, in a real-word setting, of amniotic membrane extract eye drops (AMEED) use for ocular surface disease (OSD). Methods A retrospective study of patients treated with topical AMEED between January 2018 and January 2020 was conducted. Patients were...

Full description

Saved in:
Bibliographic Details
Published in:International ophthalmology 2021-09, Vol.41 (9), p.2973-2979
Main Authors: Sabater-Cruz, Noelia, Figueras-Roca, Marc, Ferrán-Fuertes, Miriam, Agustí, Elba, Martínez-Conesa, Eva M., Pérez-Rodríguez, María Luisa, Vilarrodona, Anna, Casaroli-Marano, Ricardo P.
Format: Article
Language:English
Subjects:
Adverse events
Amniotic membrane
Clinical outcomes
Clinical trials
Cornea
Demography
Eye
Eye diseases
Health services
Mean
Medicine
Medicine & Public Health
Membranes
Ophthalmology
Original Paper
Pain
Patients
Ulcers
Wound healing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To study the indications and clinical outcomes, in a real-word setting, of amniotic membrane extract eye drops (AMEED) use for ocular surface disease (OSD). Methods A retrospective study of patients treated with topical AMEED between January 2018 and January 2020 was conducted. Patients were classified in two groups according to specific OSD—dry eye disease (DED) and wound healing delay (WHD) groups. Demographics, comorbidities, treatment duration and clinical outcomes were analysed. Results A total of 50 eyes of 36 patients with or without previous treatments were included. Patients in the DED group presented more systemic comorbidities (83 vs 22%; p  
ISSN:0165-5701
1573-2630
DOI:10.1007/s10792-021-01856-4